DUGAN RICHARD W
SEC CIK 1263499 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | Dir | 219.1K | — | $64.0K | 7 | 2022-05-31 | 2026-06-04 |
Most active insiders at VNDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | — | $1.28M |
| 2 | Moran Kevin Patrick | SVP, CFO, Treas | — | $351.0K |
| 3 | Williams Timothy | SVP, GC | — | $350.9K |
| 4 | Birznieks Gunther | SVP, Business Development | — | $350.9K |
| 5 | Wijkstrom Joakim | SVP, CMO | — | $254.7K |
| 6 | Honore Tage | Dir | — | $240.9K |
| 7 | McGuire Daniel Patrick | SVP, GC, Sec | — | — |
| 8 | Duncan Charles Cliff | Dir | — | — |
| 9 | Mitchell Stephen Ray | Dir | — | — |
| 10 | Ward Anne Sempowski | Dir | — | — |
| 12 | DUGAN RICHARD W | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-08 16:20 | 2026-06-04 | VNDA | Vanda Pharmaceuticals Inc. | DUGAN RICHARD W | Dir | A - Grant | $0.00 | +41.6K | 219.1K | +23% | $0 | |
| 2025-06-09 | 2025-06-05 | VNDA | Vanda Pharmaceuticals Inc. | DUGAN RICHARD W | Dir | A - Grant | $0.00 | +59.2K | 177.5K | +50% | $0 | |
| D | 2024-05-21 | 2024-05-17 | VNDA | Vanda Pharmaceuticals Inc. | DUGAN RICHARD W | Dir | A - Grant | $0.00 | +20.5K | 118.2K | +21% | $0 |
| D | 2023-06-12 | 2023-06-08 | VNDA | Vanda Pharmaceuticals Inc. | DUGAN RICHARD W | Dir | A - Grant | $0.00 | +17.3K | 97.7K | +22% | $0 |
| D | 2022-06-21 | 2022-06-16 | VNDA | Vanda Pharmaceuticals Inc. | DUGAN RICHARD W | Dir | A - Grant | $0.00 | +12.0K | 80.4K | +18% | $0 |
| D | 2022-06-02 | 2022-05-31 | VNDA | Vanda Pharmaceuticals Inc. | DUGAN RICHARD W | Dir | M - OptEx | $4.15 | +15.0K | 74.9K | +25% | +$62.3K |
| D | 2022-06-02 | 2022-05-31 | VNDA | Vanda Pharmaceuticals Inc. | DUGAN RICHARD W | Dir | S - Sale+OE | $9.85 | -6,500 | 68.4K | -9% | -$64.0K |
Purchase Sale Sale after option exercise All abbreviations